Combining Fas mutation with interleukin-2 deficiency prevents Colitis and Lupus: implicating interleukin-2 for auto-reactive T cell expansion and Fas ligand for colon epithelial cell death.

J Biol Chem

Division of Rheumatology and Immunology, Department of Internal Medicine, and Special Center of Research on Systemic Lupus Erythematosus, University of Virginia, Charlottesville, Virginia 22908, USA.

Published: December 2003

Both the lpr gene defect and interleukin 2-targeted mutation (IL-2 KO) in mice are lethal. Interestingly, mice bearing both mutations live significantly longer than mice with either of the single mutant genes, approximating the life span of normal controls. They do not display the major disease phenotypes of lpr and IL-2 KO mice. Systemic autoimmune response, the accumulation of the abnormal CD4-CD8-B220+ double-negative T cells, kidney disease pathology, anemia, colon damage, and lethality are prevented. Our data indicate that IL-2 is mandatory for the expansion of auto-reactive T cells in lpr mice and that CD95 (Fas) is the critical target for the development of anemia and ulcerative colitis in IL-2 KO mice in which CD178 (FasL) on intraepithelial T cells is the major effector responsible for colon damage and lethality.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M308707200DOI Listing

Publication Analysis

Top Keywords

il-2 mice
12
colon damage
8
damage lethality
8
mice
6
combining fas
4
fas mutation
4
mutation interleukin-2
4
interleukin-2 deficiency
4
deficiency prevents
4
prevents colitis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!